PhD Position in Anticancer Drug: Join our motivated team for a PraeDoc position focusing on synthesizing novel anticancer drugs with higher tumor selectivity, reducing adverse effects, and increasing efficacy. The project is part of the “Translational Cancer Therapy Research” cluster in collaboration with the Institute of Cancer Research at the Medical University of Vienna.
Summary Table:
| Extent of Employment | 30 hours/week |
|---|---|
| Job Grading | 48 WGr. B1 Grundstufe (Praedoc) |
| Gross Salary | ~34,400 Euro/year (net ~25,500 Euro/year) |
Study Area: Metal-based Anticancer Drug Development
Scholarship Description: This interdisciplinary project is part of the “Translational Cancer Therapy Research” cluster in collaboration with the Institute of Cancer Research at the Medical University of Vienna. Access state-of-the-art facilities to develop next-generation anticancer therapeutics.
Eligibility:
- MSc degree in chemistry (preferably organic or inorganic synthetic chemistry) or equivalent qualification.
- Experience in synthetic chemistry, particularly in synthesizing and characterizing (metal-based) anticancer compounds.
- Proficiency in NMR-spectroscopy, analytical HPLC(MS), preparative HPLC, and English.
- Strong verbal and written communication skills, academic teaching experience, and a team player.
Required Documents: Curriculum vitae and a letter of motivation.
How to Apply: Applications should be sent to Prof. Christian Kowol at christian.kowol@univie.ac.at.
Last Date: Application deadline is 15 December 2024.
